Using this same model, Li et al. analyzed the antitumor efficacy of cordycepin, observing a strong inhibition of tumor growth through inhibition of the FGFR/Ras/ERK pathway and deregulation of Ki67 [25]. This evidence concerns the gene MKI67 and neoplasm.